234 related articles for article (PubMed ID: 19561113)
21. Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes.
Kraus J
Ann N Y Acad Sci; 2012 Jul; 1261():1-6. PubMed ID: 22823387
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of mu-opioid receptor expression in immune and neuronal cells.
Börner C; Stumm R; Höllt V; Kraus J
J Neuroimmunol; 2007 Aug; 188(1-2):56-63. PubMed ID: 17561272
[TBL] [Abstract][Full Text] [Related]
23. Plasticity of adenylyl cyclase-related signaling sequelae after long-term morphine treatment.
Shy M; Chakrabarti S; Gintzler AR
Mol Pharmacol; 2008 Mar; 73(3):868-79. PubMed ID: 18045853
[TBL] [Abstract][Full Text] [Related]
24. The effects of electroacupuncture on TH1/TH2 cytokine mRNA expression and mitogen-activated protein kinase signaling pathways in the splenic T cells of traumatized rats.
Wang K; Wu H; Wang G; Li M; Zhang Z; Gu G
Anesth Analg; 2009 Nov; 109(5):1666-73. PubMed ID: 19843806
[TBL] [Abstract][Full Text] [Related]
25. Morphine upregulates mu opioid receptors of human and monkey lymphocytes.
Suzuki S; Miyagi T; Chuang TK; Chuang LF; Doi RH; Chuang RY
Biochem Biophys Res Commun; 2000 Dec; 279(2):621-8. PubMed ID: 11118335
[TBL] [Abstract][Full Text] [Related]
26. Hypophosphorylated TCR/CD3zeta signals through a Grb2-SOS1-Ras pathway in Lck knockdown cells.
Methi T; Ngai J; Vang T; Torgersen KM; Taskén K
Eur J Immunol; 2007 Sep; 37(9):2539-48. PubMed ID: 17683112
[TBL] [Abstract][Full Text] [Related]
27. Molecular architecture of signal complexes regulating immune cell function.
Torgersen KM; Aandahl EM; Taskén K
Handb Exp Pharmacol; 2008; (186):327-63. PubMed ID: 18491059
[TBL] [Abstract][Full Text] [Related]
28. The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation.
Evenou JP; Wagner J; Zenke G; Brinkmann V; Wagner K; Kovarik J; Welzenbach KA; Weitz-Schmidt G; Guntermann C; Towbin H; Cottens S; Kaminski S; Letschka T; Lutz-Nicoladoni C; Gruber T; Hermann-Kleiter N; Thuille N; Baier G
J Pharmacol Exp Ther; 2009 Sep; 330(3):792-801. PubMed ID: 19491325
[TBL] [Abstract][Full Text] [Related]
29. Naltrexone inhibits alcohol-mediated enhancement of HIV infection of T lymphocytes.
Wang X; Douglas SD; Peng JS; Metzger DS; O'Brien CP; Zhang T; Ho WZ
J Leukoc Biol; 2006 Jun; 79(6):1166-72. PubMed ID: 16574767
[TBL] [Abstract][Full Text] [Related]
30. The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway.
Vega Lde L; Muñoz E; Calzado MA; Lieb K; Candelario-Jalil E; Gschaidmeir H; Färber L; Mueller W; Stratz T; Fiebich BL
Biochem Pharmacol; 2005 Aug; 70(3):369-80. PubMed ID: 15922994
[TBL] [Abstract][Full Text] [Related]
31. Protein kinase D2 contributes to either IL-2 promoter regulation or induction of cell death upon TCR stimulation depending on its activity in Jurkat cells.
Irie A; Harada K; Tsukamoto H; Kim JR; Araki N; Nishimura Y
Int Immunol; 2006 Dec; 18(12):1737-47. PubMed ID: 17077180
[TBL] [Abstract][Full Text] [Related]
32. Control of lymphocyte development and activation by negative regulatory transmembrane adapter proteins.
Simeoni L; Lindquist JA; Smida M; Witte V; Arndt B; Schraven B
Immunol Rev; 2008 Aug; 224():215-28. PubMed ID: 18759929
[TBL] [Abstract][Full Text] [Related]
33. Src homology 2-domain containing leukocyte-specific phosphoprotein of 76 kDa is mandatory for TCR-mediated inside-out signaling, but dispensable for CXCR4-mediated LFA-1 activation, adhesion, and migration of T cells.
Horn J; Wang X; Reichardt P; Stradal TE; Warnecke N; Simeoni L; Gunzer M; Yablonski D; Schraven B; Kliche S
J Immunol; 2009 Nov; 183(9):5756-67. PubMed ID: 19812192
[TBL] [Abstract][Full Text] [Related]
34. Signal transduction induced by opioids in immune cells: a review.
Martin-Kleiner I; Balog T; Gabrilovac J
Neuroimmunomodulation; 2006; 13(1):1-7. PubMed ID: 16612131
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms involved in phosphatidylinositol 3-kinase pathway mediated up-regulation of the mu opioid receptor in lymphocytes.
Liu H; Li H; Guo L; Li M; Li C; Wang S; Jiang W; Liu X; McNutt MA; Li G
Biochem Pharmacol; 2010 Feb; 79(3):516-23. PubMed ID: 19765550
[TBL] [Abstract][Full Text] [Related]
36. The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor.
Wang J; Charboneau R; Balasubramanian S; Barke RA; Loh HH; Roy S
J Leukoc Biol; 2002 May; 71(5):782-90. PubMed ID: 11994502
[TBL] [Abstract][Full Text] [Related]
37. The acetaminophen-derived bioactive N-acylphenolamine AM404 inhibits NFAT by targeting nuclear regulatory events.
Caballero FJ; Navarrete CM; Hess S; Fiebich BL; Appendino G; Macho A; Muñoz E; Sancho R
Biochem Pharmacol; 2007 Apr; 73(7):1013-23. PubMed ID: 17196940
[TBL] [Abstract][Full Text] [Related]
38. Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity.
Peterson PK; Sharp B; Gekker G; Brummitt C; Keane WF
J Immunol; 1987 Jun; 138(11):3907-12. PubMed ID: 3035015
[TBL] [Abstract][Full Text] [Related]
39. A displaced PAG enhances proximal signaling and SDF-1-induced T cell migration.
Posevitz-Fejfár A; Smída M; Kliche S; Hartig R; Schraven B; Lindquist JA
Eur J Immunol; 2008 Jan; 38(1):250-9. PubMed ID: 18085663
[TBL] [Abstract][Full Text] [Related]
40. The C terminus of T cell-specific adapter protein (TSAd) is necessary for TSAd-mediated inhibition of Lck activity.
Sundvold-Gjerstad V; Granum S; Mustelin T; Andersen TC; Berge T; Shapiro MJ; Shapiro VS; Spurkland A; Lea T
Eur J Immunol; 2005 May; 35(5):1612-20. PubMed ID: 15827961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
